openPR Logo
Press release

Endometriosis Treatment Market Trends and Key Developments 2027

12-10-2017 10:34 AM CET | Health & Medicine

Press release from: Future Market Insights

Endometriosis Treatment Market Trends and Key Developments

Endometriosis is a painful chronic condition, where the tissues outlining the uterus from outside (usually found in the ovaries, fallopian tubes and ligaments supporting the uterus) rupture and lead to internal bleeding and inflammation. This can cause pain, infertility, scar tissue formation, adhesions, and bowel problems. Symptoms of endometriosis include pain before and during periods, pain with sex, infertility, fatigue, painful urination during periods, painful bowel movements during periods and other gastrointestinal upsets such as diarrhea, constipation, nausea. Although the actual cause for endometriosis is unknown, several theories indicate it could be caused due to hormonal problems, abnormal tissue growth and exposure to toxic chemicals such as dioxin. Endometriosis Association of U.S. has estimated that close to seven million females of reproductive age group suffer from the disorder only in North America. The actual number could be much larger as many patient refrain from opting for treatments. In less developed economies, the indication is still virgin signaling a green field opportunity for drug manufacturers.

Read Report Overview @ https://www.futuremarketinsights.com/reports/endometriosis-treatment-market

Edometriosis is the number one cause of infertility in the U.S. With an incidence rate of over 10% in 2016, the economic cost of endometriosis is staggering. In this regard, World Endometriosis Research Foundation (WERF) has conducted and published a prospective study of the direct and indirect costs associated with endometriosis in women over 10 different countries. The study notes that average cost of treatment per woman per year is around US$ 12,000 and overall cost of this health hazard is approximately US$ 85 Bn per year, assuming an incidence rate of 10% among women of reproductive age group.

Endometriosis is a very painful condition and often leads to infertility. In order to avoid such condition, women prefer to undergo possible treatments including surgery. In endometriosis the quality of life for patients also gets severely impacted, which provokes them to take up treatment as soon as possible. Increasing awareness for the disease, growing population of females in reproductive age group and availability of better symptom control medications are factors fuelling core research and direct disease management.

Restraints of the market include the large time framework required to diagnose the disease. Researchers have noted that on an average a seven to nine year framework is required to diagnose the disease. Availability of trial subjects based on phases of disease progression often gets blocked. There are no non-invasive diagnostic tests available for endometriosis. While an integrative treatment plan could suit a patient suffering from endometriosis at large, there are not many physicians, who recognize the benefits of such plans in most parts of the world. As such the treatment for this disease is a largely under-served domain.

Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-3870

Endometriosis Treatment Market is expected to witness significant changes due to vast opportunities remaining. However, if the length of diagnostic regimen is shortened, the rate of treatment uptake is expected to witness an uphill trend. The developed markets are expected to witness the fastest growth in terms of revenue generation in comparison with developing markets. Awareness levels being low in the less developed countries, this indication majorly leads to infertility and other things. The market once established with new treatments, is expected to witness stable growth rates in the initial years followed by dynamic rates in later years.

North America region is expected to witness faster revenue growth in comparison with markets in other regions. The reasons for the same are higher disability losses, higher treatment costs and large population of patients of reproductive age suffering from endometriosis. Higher awareness levels among physicians and frequent publication of results of upcoming treatments tend to create a positive sentiment in the region, which is absent in other regions such as Middle East and Africa and Asia. Considerable research efforts towards development of novel drugs, non-hormonal treatments and innovative minimally invasive treatment regimens are factors expected to aid the revenue growth of the market over the forecast years.

Buy Full Endometriosis Treatment Market Report @ https://www.futuremarketinsights.com/checkout/3870

Few key players in the global endometriosis treatment market are Abbvie, Eli Lilly and company, Meditrina Pharmaceuticals, AstraZeneca Plc., Pfizer Inc., Bayer AG, Neurocrine Biosciences Inc., Astellas Pharma, Takeda Pharmaceutical Company.

ABOUT US:

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:

Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Endometriosis Treatment Market Trends and Key Developments 2027 here

News-ID: 853142 • Views:

More Releases from Future Market Insights

Global Lithium Ion Battery Separator Market Projected to Reach US$ 3,256.7 Million by 2032
Global Lithium Ion Battery Separator Market Projected to Reach US$ 3,256.7 Milli …
The lithium-ion battery separator is a critical component in lithium-ion batteries, responsible for preventing short circuits and ensuring safe and efficient battery performance. It acts as a physical barrier between the positive and negative electrodes, allowing lithium ions to pass through while blocking the flow of electrons. With advancements in separator technology, these separators play a key role in enhancing battery capacity, cycle life, and overall safety in various applications,
Industrial Drums Market on a Trajectory to Reach US$ 17.6 Billion by 2027, Bolstered by a Robust 7.1% CAGR from 2022
Industrial Drums Market on a Trajectory to Reach US$ 17.6 Billion by 2027, Bolst …
The Industrial Drums Market is experiencing a steady and promising trajectory, with an estimated value of US$ 12.5 billion in 2022, projected to escalate to US$ 17.6 billion by 2027 at a commendable Compound Annual Growth Rate (CAGR) of 7.1%. This growth is substantiated by a 6.6% CAGR in volume during 2022-27, as per Future Market Insights. Anticipated to expand 1.5 times within this period, the market presents alluring prospects for industry
Supermarkets, Convenience Stores, and Eco-friendly Choices Fuel the Expansion of the Metal Cans Industry, Catering to Health-conscious and Environmentally-aware Consumers
Supermarkets, Convenience Stores, and Eco-friendly Choices Fuel the Expansion of …
The metal cans market is predicted to grow at a CAGR of 5% over the forecast period, according to research by Future Market Insights. The industry's estimated value is expected to increase from US$ 56 Bn in 2023 to US$ 91.1 Bn by 2033. The market for metal cans has been driven by the heightened demand for the product in food and beverages industry. Metal cans helps prolong shelf-life of perishable
Folding IBCs Market Poised for Growth: Expected to Reach US$ 528 Million by 2027 with a 4.8% CAGR
Folding IBCs Market Poised for Growth: Expected to Reach US$ 528 Million by 2027 …
The folding intermediate bulk containers (IBCs) market is on a growth trajectory, with an estimated value of US$ 418 million in 2022, projected to reach US$ 528 million by 2027, showcasing a Compound Annual Growth Rate (CAGR) of 4.8%. Remarkably, the China folding IBCs market defied initial pandemic-related skepticism and is anticipated to grow by 6.9% year on year in 2022. Despite global challenges, China's folding IBCs market is poised to contribute

All 5 Releases


More Releases for Endometriosis

Endometriosis Market Trends, Size, Forecast - 2018-2023
Endometriosis is a painful disorder in which the layer of tissue that normally surfaces inside the uterus, starts growing outside the uterus. This mainly occurs on the fallopian tubes, ovaries, and tissue around the uterus; however, in exceptional cases it may occur in other parts of the body. The endometriosis leads to various physical symptoms such as severe menstrual cramps, nausea and vomiting, fatigue, diarrhea, constipation, long-term pelvic pain, and
Global Endometriosis Market Research and Forecast 2018-2023
Global endometriosis market size, share, market trends, research and analysis report by diagnosis (ultrasound, pelvic exam, laparoscopy, MRI, hysteroscopy, son hysterography) by treatment (hormonal therapy, pain management) forecast 2018-2023 According to the OMR analysis, the global endometriosis market is growing at a significant rate during 2018-2023. The global endometriosis market has been growing significantly due availability of enhanced medications for the disease. The global endometriosis market is segmented on the basis
Endometriosis Therapies Market: Competitive Dynamics & Global Outlook 2023
New report published by Global Info Research which offers insights on the global Endometriosis Therapies market. Therapies used to treat endometriosis include: Hormonal contraceptives. Birth control pills, patches and vaginal rings help control the hormones responsible for the buildup of endometrialtissue each month Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/global-endometriosis-therapies-market_p87118.html Global Endometriosis Therapies Market: Forecast by Type / Application / Region The worldwide market for
Endometriosis-Pipeline Review H2 2018
Endometriosis-Pipeline Review, H2 2018 Summary Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Endometriosis-Pipeline Review, H2 2018, provides an overview of the Endometriosis (Women's Health) pipeline landscape. Endometriosis is an often painful disorder in which tissue that normally lines the inside of uterus (endometrium) grows outside uterus (endometrial implant). Symptoms include pelvic pain, menstrual cramps, inflammation, infertility and abnormal bleeding. Risk factors age, uterine abnormalities, history of pelvic infection and family history. Treatment
Global Endometriosis Market Research and Forecast 2018-2023
Endometriosis is a painful disorder in which the layer of tissue that normally surfaces inside the uterus, starts growing outside the uterus. This mainly occurs on the fallopian tubes, ovaries, and tissue around the uterus; however, in exceptional cases it may occur in other parts of the body. The endometriosis leads to various physical symptoms such as severe menstrual cramps, nausea and vomiting, fatigue, diarrhea, constipation, long-term pelvic pain, and
Global Endometriosis Treatment Market has Great Future Ahead
Qyresearchreports include new market research report Global Endometriosis Treatment Market Size,Status and Forecast 2025 to its huge collection of research reports. The comprehensive study on the global Endometriosis Treatment market recently added to our vast repository of market reports is an expansive resource for leading and new companies on the hunt for intelligent information to fabricate production and marketing strategies. The report uncovers insights on the market for Endometriosis Treatment through